Related Experiment Video
Updated: Jun 25, 2026
09:31
Visualization of Amyloid β Deposits in the Human Brain with Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry
Published on: March 7, 2019
Peripheral amyloid-beta levels regulate amyloid-beta clearance from the central nervous system
Marcos A Marques1, J Jacob Kulstad, Christopher E Savard
1Geriatric Research, Education, and Clinical Center, Seattle, WA, USA.
Journal of Alzheimer'S Disease : JAD
|February 18, 2009
Summary
Elevated peripheral amyloid-beta (Abeta) levels significantly reduce Abeta clearance from the brain. This finding supports the hypothesis that peripheral Abeta concentrations regulate central nervous system Abeta removal.
Area of Science:
- Neuroscience
- Biochemistry
- Physiology
Background:
- Amyloid-beta (Abeta) clearance from the brain involves both enzymatic breakdown and transport across the blood-brain barrier into the periphery.
- Understanding the mechanisms regulating Abeta brain clearance is crucial for developing Alzheimer's disease therapies.
Purpose of the Study:
- To investigate the impact of peripheral Abeta levels on the rate of Abeta clearance from the brain.
- To test the hypothesis that peripheral Abeta concentrations modulate central nervous system Abeta removal.
Main Methods:
- Utilized liver-ligated rats to maintain elevated peripheral Abeta levels.
- Administered radiolabeled [125I]-Abeta(1-40) into the brain to measure clearance rates.
- Compared brain clearance in rats with and without a peripheral bolus of unlabeled Abeta(1-40).
Main Results:
- Elevated peripheral Abeta levels were associated with a significant decrease in [125I]-Abeta(1-40) brain clearance.
- This demonstrates an inverse relationship between peripheral Abeta load and brain clearance efficiency.
Conclusions:
- Peripheral Abeta levels play a regulatory role in the clearance of Abeta from the central nervous system.
- Findings suggest that modulating peripheral Abeta may be a viable strategy for enhancing brain Abeta removal.
Related Concept Videos
00:49The Blood-brain Barrier
Overview
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...